Claims for Patent: 5,605,897

Summary for Patent: 5,605,897

Title:	2-methyl-thieno-benzodiazepine
Abstract:	Olanzapine, or an acid salt thereof, has pharmaceutical properties, and is of particular use in the treatment of disorders of the central nervous system. The compound has the following structure: ##STR1##
Inventor(s):	Beasley, Jr.; Charles M. (Indianapolis, IN), Chakrabarti; Jiban K. (Camberley, GB2), Hotten; Terrence M. (Farnborough, GB2), Tupper; David E. (Reading, GB2)
Assignee:	Eli Lilly and Company (Indianapolis, IN) Lilly Industries Limited (Basingstoke)
Application Number:	08/387,498
Patent Claims:	1. A method of treating a patient suffering from or susceptible to a pathological psychological condition selected from the group consisting of Moderate Mental Retardation; Severe Mental Retardation; Profound Mental Retardation; Autistic disorder; Pervasive Development Disorder NOS; Conduct Disorder, Group Type; Conduct Disorder, Solitary Aggressive Type; Tourette's Disorder; Primary Degenerative Dementia of the Alzheimer Type, Senile Onset, with Delirium; Primary Degenerative Dementia of the Alzheimer Type, Senile Onset, with Delusions; Bipolar Disorder NOS; Personality Disorders, Paranoid; Personality Disorders, Antisocial; and Personality Disorders, Borderline; which comprises administering to a patient in need thereof an effective amount of olanzapine, or an acid addition salt thereof. 2. A method of claim 1 wherein the condition is selected from the group consisting of Bipolar Disorder NOS; Personality Disorders, Paranoid; Personality Disorders, Antisocial; and Personality Disorders, Borderline. 3. A method of claim 1 wherein the condition is selected from the group consisting of Primary Degenerative Dementia of the Alzheimer Type, Senile Onset, with Delirium; and Primary Degenerative Dementia of the Alzheimer Type, Senile Onset, with Delusions. 4. A method of claim 1 wherein the effective amount is from 1 to 20 mg per day of olanzapine, or an acid addition salt thereof.